Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.280
+0.055 (2.47%)
May 13, 2025, 4:00 PM - Market closed

Lisata Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
192522205028
Upgrade
Market Cap Growth
-23.76%12.58%11.75%-60.48%81.39%6.25%
Upgrade
Enterprise Value
-7-11-32-55-50-12
Upgrade
Last Close Price
2.282.982.732.5312.6221.45
Upgrade
PS Ratio
19.1725.02----
Upgrade
PB Ratio
0.780.850.460.300.550.86
Upgrade
P/TBV Ratio
0.760.850.460.300.550.85
Upgrade
Debt / Equity Ratio
-0.010.010.010.010.02
Upgrade
Asset Turnover
0.030.02----
Upgrade
Quick Ratio
6.985.897.6710.9621.009.86
Upgrade
Current Ratio
7.526.168.1811.2621.2710.08
Upgrade
Return on Equity (ROE)
-56.92%-51.77%-36.49%-68.50%-44.21%-30.84%
Upgrade
Return on Assets (ROA)
-35.05%-31.23%-25.16%-20.00%-27.30%-37.89%
Upgrade
Return on Capital (ROIC)
-39.74%-36.07%-27.94%-21.32%-28.92%-43.99%
Upgrade
Earnings Yield
-100.71%-79.89%-93.79%-272.69%-54.59%-29.38%
Upgrade
FCF Yield
-92.63%-77.37%-90.15%-107.90%-44.33%-31.88%
Upgrade
Buyback Yield / Dilution
-3.14%-3.17%-55.85%-40.46%-258.29%-49.54%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q